Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.

Samir A Ballestas,Julio Hidalgo Lopez,Adam M Klein,Conor Steuer,Dong M Shin,Marin Abousaud,Nicole C Schmitt,Yong Teng,Nabil F Saba,Andrew T Tkaczuk

The Laryngoscope（2023）

引用 3|浏览37

暂无评分

摘要

Parenteral bevacizumab remains a well-tolerated treatment for patients with recalcitrant RRP. There appears to be a durable reduction in the frequency of debulking surgery requirements although on a maintenance regimen. Laryngoscope, 2023.

查看译文

关键词

avastin,bevacizumab,human papilloma virus (HPV),papilloma,recurrent respiratory papillomatosis (RRP)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要